{"success":true,"data":{"pressRelease":{"id":"13400","rtpr_id":"nGNE5X3rLM","ticker":"EAPI","exchange":"Euronext Paris","all_tickers":["EAPI"],"title":"REG-Availabilty of 2026 AGM preparatory documents","author":"Globe Newswire","published_at":"2026-04-29T16:00:00.111Z","article_body":"Press Release  Paris, 29 April, 2026  \n\nCombined General Meeting of May 27, 2026 \nAvailability of preparatory documents\n\nEUROAPI’s shareholders are invited to attend the Combined General Meeting to\nbe held on Wednesday May 27, 2026, at 10:00 a.m. (CET) at 15 bis, rue\nTraversière 75012 Paris (Théâtre Traversière).\n\nThe notice of meeting was published in the French official legal announcement\npublication (BALO) on Wednesday April 20, 2026 (Bulletin BALO n°48 du\n22/04/2026, affaire n°2601097 | journal-officiel.gouv.fr\n(https://www.globenewswire.com/Tracker?data=MUqgvnAywkkD7NPshyDONXRclnVZNmO4mFCwqcim0YKcYpkKqbvLAOJ0OHuc877jFzhl3hoRP7O6ZEGO9ruZzTbPOi08cHMbY-esSXx1hrzz-ZG4zZAACMdH8L3VgVnbisXQguLmwsyyqLrKGAln3bvCS84-v_3yMZnhl1iS1pWfov4toyMUu7J4th3sJwykBT_Frvmq19rOboAxrDyCd_Sbj-rIwaN8ir9cSCaFVuoH31PV6cZv8yQqg8tz7ceFzLx4n7I9qSHIxr4__URZH3TPE3O-Q6lxqeJsmi-Gcf8=))\n\nThe convening notice (avis de convocation) was published in the French\nofficial legal announcement publication (BALO), on April 29, 2025 (Bulletin\nBALO n°51 du 29/04/2026, affaire n°2601292 | journal-officiel.gouv.fr\n(https://www.globenewswire.com/Tracker?data=MUqgvnAywkkD7NPshyDONYcynYYQleUCTbYW_Fkc8d7GS9CqWC-03GP7U3kXemazaih-njx-JDiT2f9LjYtzIzB-L06YBr4f-9eT6QYOrHXo3wsmucS9oKBkI-gjQZulSqvYMuHK6Xy5z25m54JmyOSH-kYfhh9tREbOSM_JqwCAR3OhI_7lz9Rk4obDCYN8oPbMfbd-3c3ej8M6h1QX1bIXmBqRHY86smhoPylIgEupq34hM0AP1BV8e3Fg1IgN7lMbD6_a8SP2lHrtMGMNXrZsGDh_VxOcNVO8XTLiflw=))\nand in lefigaro.fr, a French journal of legal notice (n°  L0239073)\n\nIn accordance with the law, shareholders may consult the preparatory documents\nfor this meeting on the Company’s website in the section entitled “Annual\nGeneral Meeting 2026” (Annual General Meetings | EUROAPI\n(https://www.globenewswire.com/Tracker?data=4Zd89-NyYGiDBHvubjwIikGHW1b1RZwfpA-6EZxBrihimyuBZ7jj7SZrdLiptrnkBpkW0gexejwRZw4bd-bS4D12Ez8peSIERazP0ax_Jg57OMcKfZm_0s2ICyqqDnNIBLQYG9LtnlQHacIJ6yaTxap-DQ8EGp-KzZMIMFQlLrOWAqz6vi0h3xREs2srEXrBxvfuhcQpwtGiJJ4qFSYP6Q==)).\n\nShareholders are invited to regularly consult the Annual General Meetings\nsection of EUROAPI’s website, which will be updated with any changes\nregarding participation in the meeting.\n\nAbout EUROAPI\n\nEUROAPI is focused on reinventing active pharmaceutical ingredients to\nsustainably meet customers’ and patients’ needs around the world. We are a\nleading player with approximately 200 products in our portfolio, offering a\nlarge span of technologies while also developing innovative molecules through\nour Contract Development and Manufacturing Organization (CDMO) activities.\nWith strong R&D capabilities and five manufacturing sites located in Europe,\nEUROAPI provides its clients with high-quality API solutions in more than 80\ncountries. Our 3000+ people are committed to building together the future of\npublic health by advancing and securing access to essential active\ningredients, at the core of the healthcare value chain. EUROAPI is listed on\nEuronext Paris: EAPI. Find out more at www.euroapi.com and follow us\non LinkedIn\n(https://www.globenewswire.com/Tracker?data=VzCoYCTTO_YgchgwsWEm54mbPEHcF3vqdjdyx1rbw4sTDxk5yK0gDZUL-wiO-Cq8e3xAbT10UWwyyumojD1hMkbIim2oBG2a0qKMLyvG2JbOeHYxYF2Yk__ngPlHlfXb).\n\n Media Relations contact: Laurence Bollack Tel.: +33 (0)6 81 86 80 19 mr@euroapi.com  Investor Relations contact: Sophie Palliez-Capian Tel.: +33 (0)6 87 89 33 51 Sophie.palliez@euroapi.com   Léa Massonneau Tel: +33 (0)7 60 32 29 50 lea.massonneau@euroapi.com   \n\nAttachment\n*     Euroapi_Availabilty of 2026 AGM preparatory documents_29APR26\n(https://ml-eu.globenewswire.com/Resource/Download/a6310d13-0b74-41f8-a7f7-4fad2e3c0ffe)","article_body_html":"","raw_payload":{"data":{"id":"nGNE5X3rLM","title":"REG-Availabilty of 2026 AGM preparatory documents","author":"Globe Newswire","ticker":"EAPI","created":"2026-04-29T16:00:00.111Z","tickers":["EAPI"],"exchange":"Euronext Paris","article_body":"Press Release  Paris, 29 April, 2026  \n\nCombined General Meeting of May 27, 2026 \nAvailability of preparatory documents\n\nEUROAPI’s shareholders are invited to attend the Combined General Meeting to\nbe held on Wednesday May 27, 2026, at 10:00 a.m. (CET) at 15 bis, rue\nTraversière 75012 Paris (Théâtre Traversière).\n\nThe notice of meeting was published in the French official legal announcement\npublication (BALO) on Wednesday April 20, 2026 (Bulletin BALO n°48 du\n22/04/2026, affaire n°2601097 | journal-officiel.gouv.fr\n(https://www.globenewswire.com/Tracker?data=MUqgvnAywkkD7NPshyDONXRclnVZNmO4mFCwqcim0YKcYpkKqbvLAOJ0OHuc877jFzhl3hoRP7O6ZEGO9ruZzTbPOi08cHMbY-esSXx1hrzz-ZG4zZAACMdH8L3VgVnbisXQguLmwsyyqLrKGAln3bvCS84-v_3yMZnhl1iS1pWfov4toyMUu7J4th3sJwykBT_Frvmq19rOboAxrDyCd_Sbj-rIwaN8ir9cSCaFVuoH31PV6cZv8yQqg8tz7ceFzLx4n7I9qSHIxr4__URZH3TPE3O-Q6lxqeJsmi-Gcf8=))\n\nThe convening notice (avis de convocation) was published in the French\nofficial legal announcement publication (BALO), on April 29, 2025 (Bulletin\nBALO n°51 du 29/04/2026, affaire n°2601292 | journal-officiel.gouv.fr\n(https://www.globenewswire.com/Tracker?data=MUqgvnAywkkD7NPshyDONYcynYYQleUCTbYW_Fkc8d7GS9CqWC-03GP7U3kXemazaih-njx-JDiT2f9LjYtzIzB-L06YBr4f-9eT6QYOrHXo3wsmucS9oKBkI-gjQZulSqvYMuHK6Xy5z25m54JmyOSH-kYfhh9tREbOSM_JqwCAR3OhI_7lz9Rk4obDCYN8oPbMfbd-3c3ej8M6h1QX1bIXmBqRHY86smhoPylIgEupq34hM0AP1BV8e3Fg1IgN7lMbD6_a8SP2lHrtMGMNXrZsGDh_VxOcNVO8XTLiflw=))\nand in lefigaro.fr, a French journal of legal notice (n°  L0239073)\n\nIn accordance with the law, shareholders may consult the preparatory documents\nfor this meeting on the Company’s website in the section entitled “Annual\nGeneral Meeting 2026” (Annual General Meetings | EUROAPI\n(https://www.globenewswire.com/Tracker?data=4Zd89-NyYGiDBHvubjwIikGHW1b1RZwfpA-6EZxBrihimyuBZ7jj7SZrdLiptrnkBpkW0gexejwRZw4bd-bS4D12Ez8peSIERazP0ax_Jg57OMcKfZm_0s2ICyqqDnNIBLQYG9LtnlQHacIJ6yaTxap-DQ8EGp-KzZMIMFQlLrOWAqz6vi0h3xREs2srEXrBxvfuhcQpwtGiJJ4qFSYP6Q==)).\n\nShareholders are invited to regularly consult the Annual General Meetings\nsection of EUROAPI’s website, which will be updated with any changes\nregarding participation in the meeting.\n\nAbout EUROAPI\n\nEUROAPI is focused on reinventing active pharmaceutical ingredients to\nsustainably meet customers’ and patients’ needs around the world. We are a\nleading player with approximately 200 products in our portfolio, offering a\nlarge span of technologies while also developing innovative molecules through\nour Contract Development and Manufacturing Organization (CDMO) activities.\nWith strong R&D capabilities and five manufacturing sites located in Europe,\nEUROAPI provides its clients with high-quality API solutions in more than 80\ncountries. Our 3000+ people are committed to building together the future of\npublic health by advancing and securing access to essential active\ningredients, at the core of the healthcare value chain. EUROAPI is listed on\nEuronext Paris: EAPI. Find out more at www.euroapi.com and follow us\non LinkedIn\n(https://www.globenewswire.com/Tracker?data=VzCoYCTTO_YgchgwsWEm54mbPEHcF3vqdjdyx1rbw4sTDxk5yK0gDZUL-wiO-Cq8e3xAbT10UWwyyumojD1hMkbIim2oBG2a0qKMLyvG2JbOeHYxYF2Yk__ngPlHlfXb).\n\n Media Relations contact: Laurence Bollack Tel.: +33 (0)6 81 86 80 19 mr@euroapi.com  Investor Relations contact: Sophie Palliez-Capian Tel.: +33 (0)6 87 89 33 51 Sophie.palliez@euroapi.com   Léa Massonneau Tel: +33 (0)7 60 32 29 50 lea.massonneau@euroapi.com   \n\nAttachment\n*     Euroapi_Availabilty of 2026 AGM preparatory documents_29APR26\n(https://ml-eu.globenewswire.com/Resource/Download/a6310d13-0b74-41f8-a7f7-4fad2e3c0ffe)"},"type":"article","timestamp":"2026-04-29T16:00:00.285744144Z","server_sent_at_ms":1777478400285},"received_at":"2026-04-29T16:00:00.354Z","source_url":"https://www.globenewswire.com/news-release/2026/04/29/3284078/0/en/Availabilty-of-2026-AGM-preparatory-documents.html"},"analysis":{"id":"10321","press_release_id":"13400","analysis_json":{"industry":{"label":"Pharmaceuticals, Biotechnology & Life Sciences","sector":"Health Care"},"redFlags":[],"eventType":"other","narrative":"EUROAPI announced the availability of preparatory documents for its Combined General Meeting scheduled for May 27, 2026, at 10:00 a.m. CET in Paris.\n\nThe convening notice was previously published in the French official legal announcement publication (BALO) and lefigaro.fr, with shareholders instructed to consult the company's website for updates.\n\nThe company operates as a Contract Development and Manufacturing Organization (CDMO) with approximately 200 products and manufacturing sites across Europe.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine administrative notice regarding AGM documentation availability."},"keyFigures":{},"quotedText":"","namedEntities":{"people":[{"name":"Laurence Bollack","role":"Media Relations"},{"name":"Sophie Palliez-Capian","role":"Investor Relations"},{"name":"Léa Massonneau","role":"Investor Relations"}],"products":[],"companies":[{"name":"EUROAPI","ticker":"EAPI"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Routine administrative announcement regarding the availability of preparatory documents for the Annual General Meeting. No financial or operational updates were provided."},"tickerRelevance":{"others":[],"primary":"EAPI"},"globalImportance":5,"audienceRelevance":15,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"Mid-cap","eventGravity":"Routine administrative","sectorWeight":"Pharma"}},"event_type":"other","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"EUROAPI announced the availability of preparatory documents for its Combined General Meeting scheduled for May 27, 2026, at 10:00 a.m. CET in Paris.\n\nThe convening notice was previously published in the French official legal announcement publication (BALO) and lefigaro.fr, with shareholders instructed to consult the company's website for updates.\n\nThe company operates as a Contract Development and Manufacturing Organization (CDMO) with approximately 200 products and manufacturing sites across Europe.","key_figures":{},"named_entities":{"people":[{"name":"Laurence Bollack","role":"Media Relations"},{"name":"Sophie Palliez-Capian","role":"Investor Relations"},{"name":"Léa Massonneau","role":"Investor Relations"}],"products":[],"companies":[{"name":"EUROAPI","ticker":"EAPI"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:1fc968c3ac7f7ebb","schema_hash":"sha256:1f8af1196c7db48c","created_at":"2026-04-29T19:13:15.091Z","global_importance":5,"audience_relevance":15,"importance_components":{"tickerTier":"Mid-cap","eventGravity":"Routine administrative","sectorWeight":"Pharma"}},"durationMs":69740,"modelName":"glm-4.7"}}